What happens when you take rosuvastatin with red yeast rice?
Red yeast rice is often thought of as a gentle, "natural" cholesterol supplement, but it is not chemically neutral. Its active ingredient is monacolin K, which is structurally identical to the prescription statin lovastatin. That means red yeast rice is, in effect, a low and unregulated dose of a statin sold as a supplement.
Rosuvastatin is also a statin. It works by blocking the same enzyme in the liver, HMG-CoA reductase, that monacolin K blocks. So when you take red yeast rice alongside rosuvastatin, you are stacking a second statin-like compound on top of your prescription statin. The two do the same job through the same pathway, which adds to your total statin-class exposure.
Importantly, this is an additive interaction, not an enzyme-based one. Rosuvastatin is not broken down by the CYP3A4 liver enzyme, so red yeast rice does not slow its clearance or spike its blood levels the way it can with some other statins. The concern here is simpler: two statin-type agents doing overlapping work at the same time.
Why is this important?
Statins, including the statin-like monacolin K in red yeast rice, share the same characteristic risks: muscle injury (myopathy, and rarely the serious muscle breakdown called rhabdomyolysis) and, less commonly, liver injury. Stacking a second statin-class agent on top of rosuvastatin can modestly raise the combined potential for these effects beyond either product alone.
In practice the added statin burden is usually small, because the monacolin content of red yeast rice is typically low, highly variable, and not shown on the label. But "usually small" is not the same as "predictable." Because these products are unregulated, some high-monacolin red yeast rice products can carry a more meaningful statin-like load, which pushes the additive risk upward. You have no reliable way to know from the packaging which kind you are holding.
This is why the combination is best treated as taking two statins rather than a statin plus a harmless supplement.
What should you do?
The core principle: treat red yeast rice as a second statin, not a neutral add-on, and loop in your doctor or pharmacist before combining it with rosuvastatin.
- Before starting: Review the combination with your doctor or pharmacist first. Tell them you are already on rosuvastatin, and flag any existing liver concern or history of muscle problems on statins. Do not add red yeast rice on your own.
- While taking both: Watch for warning signs of statin-type injury, unexplained muscle pain, tenderness, or weakness, or dark or tea-colored urine. If any of these appear, contact your clinician promptly rather than waiting.
- On timing and spacing: Because this is an additive effect and not an enzyme-based one, separating the two by a few hours does not remove the concern, the total statin-class load is what matters, not the gap between doses. The meaningful decision is whether to take both at all, which is a clinician's call.
- Never adjust on your own: Do not stop, start, or change the dose of either product without medical advice. Stopping your prescription statin unsupervised carries its own cardiovascular risk.
Which specific products are affected?
This applies to rosuvastatin in all its forms, whether prescribed under a brand name or as a generic.
On the supplement side, it applies to any product containing red yeast rice (also labeled as Monascus purpureus, red rice, or containing monacolin K). Because monacolin content is not shown on the label and varies widely between products, you cannot judge a given product's statin-like strength from the packaging. Some products are marketed as "monacolin-free" or standardized, but the variability across the category means all red yeast rice products warrant the same caution when combined with a prescription statin. The same principle extends to any multi-ingredient cholesterol or "heart health" supplement that lists red yeast rice among its ingredients.
The science behind it
The clearest framing comes from the U.S. National Center for Complementary and Integrative Health (NCCIH), which states that red yeast rice's active compound, monacolin K, is structurally identical to the statin lovastatin. NCCIH notes that red yeast rice products can therefore carry the same drug-interaction potential and the same muscle, kidney, and liver injury risks as statins, and that monacolin content is unlabeled and varies enormously from product to product. This is the basis for treating red yeast rice as a statin rather than a benign supplement.
Two clinical studies keep this interaction in the moderate rather than severe range. In a randomized clinical trial by Tavan and colleagues (BMC Nutrition, 2022; PMID 36434733), red yeast rice was added to ongoing statin therapy and was found to be safe with respect to liver function over the study period, suggesting the added burden is often modest in practice. Separately, Rigillo and colleagues (Phytotherapy Research, 2025; PMID 39511729) compared red yeast rice against isolated lovastatin and found that the red yeast rice samples had a lower impact on skeletal-muscle cells than lovastatin alone, again pointing to a generally smaller effect than an equivalent statin dose.
The evidence therefore points in two directions at once: red yeast rice is genuinely a statin (NCCIH), but its real-world impact when added to a statin is usually limited (Tavan, Rigillo). The reason caution still applies is the unregulated, unpredictable monacolin content, which can be higher than expected in some products. That combination, real statin-class risk plus unpredictability, is why clinician review is warranted rather than dismissing the pairing.
Frequently Asked Questions
Isn't red yeast rice a natural supplement rather than a drug?
It is sold as a supplement, but its active compound, monacolin K, is chemically identical to the prescription statin lovastatin. NCCIH describes it as carrying the same interaction and injury risks as statins, so functionally it behaves like a low, unregulated dose of a statin.
Does rosuvastatin interact with red yeast rice through the liver enzymes?
No. Rosuvastatin is not broken down by the CYP3A4 enzyme, so red yeast rice does not slow its clearance or raise its blood levels through that pathway. The interaction here is purely additive, two statin-type agents working at the same time, rather than one amplifying the other.
Can I just space them a few hours apart to be safe?
Spacing helps with enzyme-based interactions, but this one is additive, so the total statin-class exposure across the day is what matters, not the gap between doses. The real question is whether to take both at all, which is a decision for your doctor or pharmacist.
What symptoms should make me stop and call my doctor?
Unexplained muscle pain, tenderness, or weakness, and dark or tea-colored urine, are the classic warning signs of statin-type muscle injury. If you notice any of these while taking both, contact your clinician promptly. Do not wait to see if it passes.
If studies say adding red yeast rice to a statin is usually safe, why the caution?
Because monacolin content is unlabeled and varies widely between products. The studies show the added burden is often modest, but you cannot tell from the label whether a given product carries a small or a more meaningful statin-like load, so a clinician should weigh it in.
Can I stop my rosuvastatin and just use red yeast rice instead?
Not on your own. Stopping a prescription statin without medical guidance carries real cardiovascular risk, and red yeast rice is an unregulated, unpredictable statin substitute. Any switch or change should be made only with your doctor or pharmacist.
Key takeaways
- Red yeast rice is effectively a statin, its active compound monacolin K is chemically identical to lovastatin, so combining it with rosuvastatin stacks two statin-class agents.
- The interaction is additive, not enzyme-based, rosuvastatin is not cleared by CYP3A4, so the concern is combined statin exposure, not one drug amplifying the other.
- The main risks are statin-type muscle injury and, less commonly, liver injury, watch for muscle pain or weakness and dark urine.
- The added burden is usually small but unpredictable, monacolin content is unlabeled and varies widely, and some products carry a more meaningful load.
- Treat red yeast rice as a second statin, review the combination with your doctor or pharmacist, and never start or stop either product on your own.